Spine surgeon Mark McFarland, DO, performed a surgery with SpineFrontier's REmind pedicle screw system and LES P-LIFT interbody cages as well as NanoFuse Bioactive Matrix.
Biologics
The FDA granted Wright Medical Group premarket approval for its Augment Injectable Bone Graft.
The University Medical Center Utrecht in the Netherlands will begin a study comparing Kuros Biosciences' MagnetOs with autologous bone in posterolateral spinal fusion.
Cerapedics earned the 2018 MedTech Breakthrough Award for Best New Surgical Technology Solution.
Tulsa, Okla.-based Edison Healthcare partnered with Regenexx to offer its employees alternatives to orthopedic surgery.
Advertisement
NuVasive launched the AttraX Scaffold in the U.S. for use in the posterolateral spine to promote fusion.
The global spine biologics market is expected to grow at a compound annual growth rate of 4.09 percent from 2018 to 2022, according to a 360 Market Updates report.
Lattice Biologics is a regenerative medicine company that develops biologic allograft products for bone, skin and cartilage solutions.
Here are eight Q&As on the application of biologics in orthopedics and spine.
International Stem Cell Corporation plans to launch its advanced joint supplement for the treatment of osteoarthritis-related joint pain in the third quarter of 2018.